JORDAN DANIELS: Open Payments
NPI 1093441891 · HENDERSON, NV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$6,198 in 156 payments from 15 companies in 2025. Trend: 2023 $1,921 · 2024 $3,077 · 2025 $6,198
Food & beverage: $3,129Consulting: $2,325Speaker / faculty: $534Education: $210
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 19 | $3,178 |
| Galderma Laboratories, L.P. | 17 | $665 |
| ABBVIE INC. | 20 | $386 |
| Janssen Biotech, Inc. | 14 | $380 |
| UCB, Inc. | 14 | $265 |
| GENZYME CORPORATION | 15 | $260 |
| LEO Pharma Inc. | 14 | $249 |
| Regeneron Healthcare Solutions, Inc. | 9 | $197 |
| Incyte Corporation | 5 | $185 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 9 | $160 |
Products named: CIBINQO, NEMLUVIO, DUPIXENT, TREMFYA, Bimzelx, RINVOQ, ADBRY, OPZELURA.
Industry payments across NV — which companies pay providers there.
